FDA Inspection 1311376 - The Procter & Gamble Manufacturing Company - June 09, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore The Procter & Gamble Manufacturing Company

Record Details

This FDA Inspection record concerns The Procter & Gamble Manufacturing Company, with an inspection on June 9, 2026, issued by the Atlanta District Office, covering human drugs.

Company: The Procter & Gamble Manufacturing Company
Inspection Date: June 9, 2026
Product Type: Human Drugs
Office: Atlanta District Office

Open in Dashboard

ID · 6f5ce3be-5e9d-4013-9ec7-ed94a5bd0e03

Violation Codes4

21 CFR 211.115(a)21 CFR 211.166(a)21 CFR 211.19221 CFR 211.194(a)(1)

Full citation text and observation details available on the Dashboard.